Key facts
- Viol’s last known valuation is $1.1B (Jun 2025).
- It has raised $47.4M; the latest was Buyout/LBO in Jul 2025.
- Notable investors include VIG Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Viol
- ·The full record, as it builds
Funding rounds
No funding rounds for Viol are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Viol
VIOL Co Ltd is engaged in manufacturing and marketing of medical devices for skincare treatment and recovery. The product portfolio includes SkinStamp, SYLFIRM, SCARLET, O Media - RS, O Media - RI, and O Media - Hmgf H.
- Sector
- Healthcare
- HQ
- Seongnam-si, South Korea
- Founded
- 2009
- Employees
- 109
- Website
- viol.co.kr/
- Ownership
- Privately Held (backing)
Viol doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Viol shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Viol in its N-PORT filings yet. We sweep new filings monthly.